A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients
Clinical trial NCT00845026 · COMPLETED
Trial details
- NCT number
- NCT00845026
- Sponsor
- Denovo Biopharma LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2010-05-01
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.